Literature DB >> 21604072

Role of transoral CO(2) laser surgery for severe pediatric laryngomalacia.

Sachin Gandhi1, Vasant Oswal, Pallavi Thekedar, Prasun Mishra.   

Abstract

Controversy exists as to the preferred treatment modality for managing refractory pediatric laryngomalacia (LM). Simultaneous bilateral procedures have been associated with supraglottic stenosis. Unilateral operations have a higher rate of secondary intervention. This prospective study was conceptualized to ascertain a preferred approach. A secondary goal was to correlate the surgical outcome with presenting symptoms and signs. Twenty-two children with severe LM met the criteria for enrollment. Bilateral CO(2) laser-assisted supraglottic laryngoplasties were performed in all cases. The procedure mainly consisted of division of the aryepiglottic fold. Nineteen (86%) patients met our defined success criteria. There were no surgical complications. Bilateral supraglottic laryngoplasty has a role in the management of severe refractory LM.

Entities:  

Mesh:

Year:  2011        PMID: 21604072     DOI: 10.1007/s00405-011-1631-x

Source DB:  PubMed          Journal:  Eur Arch Otorhinolaryngol        ISSN: 0937-4477            Impact factor:   2.503


  22 in total

1.  Microdebrider-assisted supraglottoplasty.

Authors:  George H Zalzal; William O Collins
Journal:  Int J Pediatr Otorhinolaryngol       Date:  2004-12-08       Impact factor: 1.675

2.  Unilateral vs. bilateral supraglottoplasty for severe laryngomalacia in children.

Authors:  D K Reddy; B H Matt
Journal:  Arch Otolaryngol Head Neck Surg       Date:  2001-06

3.  Use of the CO2-laser micropoint micromanipulator for the treatment of laryngomalacia.

Authors:  M Remacle; E Bodart; G Lawson; M Minet; A Mayné
Journal:  Eur Arch Otorhinolaryngol       Date:  1996       Impact factor: 2.503

4.  [Laryngeal anomalies in newborn infants. Apropos of 687 cases].

Authors:  P Narcy; S Bobin; P Contencin; C Le Pajolec; Y Manac'h
Journal:  Ann Otolaryngol Chir Cervicofac       Date:  1984

5.  Aryepiglottic fold excision for the treatment of severe laryngomalacia.

Authors:  J M Polonovski; P Contencin; M Francois; P Viala; P Narcy
Journal:  Ann Otol Rhinol Laryngol       Date:  1990-08       Impact factor: 1.547

6.  Laryngomalacia and its treatment.

Authors:  D R Olney; J H Greinwald; R J Smith; N M Bauman
Journal:  Laryngoscope       Date:  1999-11       Impact factor: 3.325

7.  Aryepiglottoplasty for laryngomalacia: the Alder Hey experience.

Authors:  J E Martin; K E Howarth; I Khodaei; A Karkanevatos; R W Clarke
Journal:  J Laryngol Otol       Date:  2005-12       Impact factor: 1.469

8.  Epiglottoplasty for the treatment of laryngomalacia.

Authors:  G H Zalzal; J B Anon; R T Cotton
Journal:  Ann Otol Rhinol Laryngol       Date:  1987 Jan-Feb       Impact factor: 1.547

9.  Laser division of the aryepiglottic folds for severe laryngomalacia.

Authors:  A B Seid; S M Park; M J Kearns; S Gugenheim
Journal:  Int J Pediatr Otorhinolaryngol       Date:  1985-11       Impact factor: 1.675

10.  Laryngomalacia. The search for the second lesion.

Authors:  R F Mancuso; S S Choi; G H Zalzal; K M Grundfast
Journal:  Arch Otolaryngol Head Neck Surg       Date:  1996-03
View more
  3 in total

1.  Flexible bronchoscopy as a valuable tool in the evaluation of infants with stridor.

Authors:  Ela Erdem; Yasemin Gokdemir; Fusun Unal; Refika Ersu; Bulent Karadag; Fazilet Karakoc
Journal:  Eur Arch Otorhinolaryngol       Date:  2012-05-26       Impact factor: 2.503

2.  Treatment outcome of supraglottoplasty vs. wait-and-see policy in patients with laryngomalacia.

Authors:  Martijn van der Heijden; Frederik G Dikkers; Gyorgy B Halmos
Journal:  Eur Arch Otorhinolaryngol       Date:  2016-02-29       Impact factor: 2.503

3.  Surgical treatment of severe laryngomalacia: a retrospective study of 11 case.

Authors:  José Antonio Pinto; Henrique Wambier; Elcio Izumi Mizoguchi; Leonardo Marques Gomes; Rodrigo Kohler; Renata Coutinho Ribeiro
Journal:  Braz J Otorhinolaryngol       Date:  2013 Sep-Oct
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.